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Rotaviruses (RVs), which are members of the family *Reoviridae*, are a common cause of viral gastroenteritis in humans and in the young of various vertebrates ([@B1]). Rotavirus possesses an RNA genome composed of 11 double-stranded segments, encoding six structural (VPs) and five nonstructural proteins (NSPs) ([@B1]). The genome is assigned the complete descriptor of Gx-P\[x\]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx for VP7, VP4, VP6, VP1 to VP3, and NSP1-5/6, respectively, with x indicating the numbers of corresponding genotypes ([@B2]). RVs are classified into eight antigenically defined groups, rotavirus A to H (RVA to RVH) ([@B3]). RVA strains are well known for their high prevalence and pathogenesis in humans and animals, possessing either Wa-like genogroup 1 constellation (G1-P\[1\]-I1-R1-C1-M1-A1-N1-T1-E1-H1) or Ds-1-like genogroup 2 constellation (G2-P\[2\]-I2-R2-C1-M2-A2-N2-T2-E2-H2). RVB, RVC, and RVH are also known to infect humans and a limited number of animals. RVD, RVE, RVF, and RVG have been detected only in birds or pigs ([@B2], [@B4]). In 1997, a rotavirus strain infecting humans, adult diarrhea rotavirus (ADRV-N) ([@B5], [@B6]), was identified, which did not belong to previously established groups; however, it was later identified as RVH, based on VP6 sequence analysis ([@B3]). Subsequently, RVH has been detected in humans, as strain J19 in China ([@B7]), strain B219 in Bangladesh ([@B5], [@B8]), and in pigs from Japan ([@B9]), Brazil ([@B10]), and South Africa ([@B11]).

Here, we report the first genomic sequence for all 11 segments of a porcine RVH strain from the United States. On 16 April 2008, the University of Minnesota Veterinary Diagnostic Laboratory received three intestinal samples from 4-week-old pigs with clinical signs of diarrhea, coughing, and failure to thrive. These samples from Minnesota were homogenized together, as previously described ([@B12]), and determined to be positive for RVA, RVB, RVC, and RVH by reverse transcription-PCR (RT-PCR) ([@B13], [@B14]).

We used a previously described viral metagenomics approach to enrich and sequence viral nucleic acids, followed by MiSeq and *de novo* assembly of the resulting reads ([@B15]). Briefly, viral RNA was reversely transcribed and amplified using a random primer. A next-generation sequencing (NGS) library was prepared, using the Nextera XT kit; sequencing followed using Illumina's MiSeq platform. A total of 766,560 reads were generated, *de novo* assembled, and analyzed in the bioinformatics pipeline, as described previously ([@B16]).

We obtained the following near-complete sequences for RVH strain MN9.65: for VP1 (segment 1, 3,369 bp); VP2 (segment 2, 2,977 bp); VP3 (segment 3, 1,167 bp); VP4 (segment 4, 1,275 bp); NSP1 (segment 5, 1,248 bp), the only segment containing the entire coding region; NSP3 (segment 7, 408 bp); NSP2 (segment 8, 913 bp); VP7 (segment 9, 456 bp); NSP4 (segment 10, 687 bp); and NSP5/6 (segment 11, 493 bp). The VP6 gene was deposited previously ([@B14]). This RVH strain MN9.65 shares 88% (VP1), 90% (VP2), 90% (VP3), 88% (VP4), 82% (VP7), 88% (NSP1), 90% (NSP2), 94% (NSP3), and 85% (NSP4) nucleotide identity with porcine RVH strain SKA-1 from Japan. Obtaining all 11 segments of RVH will facilitate further rotavirus H surveillance in pigs globally and allow for the development of improved screening methods for RVH strains.
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The sequences for RHV/MN9.65/2008 have been deposited in GenBank under accession numbers [KU254582](KU254582) to [KU254592](KU254592).
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